Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 701–777 of 777
Changes in gut microbiome as important risk- factor for development of metabolic diseases
Tkach, S. M., Ларін, О. С., & Підаєв, А. В. (2017) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.1(57).2017.96971 · Cited by 2
“С функциональной точки зрения, защитная роль комменсальной кМ при Сд 1 типа может быть объяснена тем, что микробиотные метаболиты, такие как кцжк, укрепляют целостность слизистой и модулируют выработку гормонов, улучшая метаболизм глюкозы, уменьшая воспаление и снижая число потенциальных провоспалительных бактерий (на…”
The Microbiota-Obesity Connection, Part 2
Ross, S. M. (2017) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000213
Modulation of the gut microbiota and implications for host health
Patterson, E. (2014) · Cork Open Research Archive (University College Cork, Ireland) · Cited by 1
Exercise and Dietary Factors Affecting the Microbiota: Current Knowledge and Future Perspectives
Marroquín, F. E. M. (2017) · Journal of Nutritional Health & Food Engineering · doi:10.15406/jnhfe.2017.06.00199
“these two bacteria groups have the capability of forming lactate, which is later converted into butyrate by butyrate-producing bacteria in the gut [4].”
BackgroundGenome-environment Interactions in Type 1 Diabetes
Markle, J. (2013) · TSpace (University of Toronto)
Type I Diabetes and Human Microbiome
Madupu, R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6418-1_754-1
Demırci, M., Keskin, F. E., Taner, Z., Özyazar, M., Kocazeybek, B., & Tokman, H. B. (2019) · Journal of Academic Research in Medicine · doi:10.5152/jarem.2018.2122
Breastfeeding and Autoimmunity
Borba, V. V., Sharif, Κ., & Shoenfeld, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00028-1
The Role of Omic Technologies in the Study of the Human Gut Microbiome
Sen, P., Lamichhane, S., Dickens, A. M., & Orešič, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22922-3
Kulkarni, A. (2020) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1921
Human Gut Microbiota: Friend or Foe?
Pliszka, M., & Szablewski, L. (2020) · OBM Hepatology and Gastroenterology · doi:10.21926/obm.hg.2003050 · Cited by 1
Caracterização da microbiota fecal de cães obesos e após emagrecimento
Macedo, H. T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2020.tde-18052020-102343 · Cited by 2
Tracking the humoral immune response in type 1 diabetes
Bian, X. (2015)
مقایسه ی اثر Akkermansia muciniphila زنده و پاستوریزهدر کنترل چاقی و دیابت
Shahryari, A., Tavassol, Z. H., Soroush, A., Ejtahed, H., & Larijani, B. A. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)
Statistical, visual and functional analysis of microbiome data
Dhariwal, A. (2018) · doi:10.82308/54547 · Cited by 3
Understanding biological factors associated with pelvic organ prolapse in late gestation sows
Kiefer, Z. E. (2021) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210609-87 · Cited by 1
Microbial Diversity and Classification
Wilkinson, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00055-0
مروری بر اثرات مفید پروبیوتیک ها در پیشگیری و درمان بیماریها
Safdari, M., Razi, A., Safarirad, M., Pournaghi, S.-J., Shekari, S., Alesheikh, P., & Rameshrad, M. (2021) · Journal of North Khorasan University of Medical Sciences · doi:10.29252/nkjms-13019
Bayesian Statistical Modeling of Metagenomics Sequencing Data
Jiang, S. (2021) · SMU Scholar (Southern Methodist University)
Gut microbiota in relation to glycemic status in rural & urban Chinese people
Kim, Y. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/1z2h-px36
Amaral, A. R. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2020.tde-21012021-093129 · Cited by 1
Piegorsch, W. W., & Young, L. J. (2021) · Wiley eBooks · doi:10.1002/9781118445112.stat08218
Inflammatory Pathways Linked to β Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_30
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00749-5
Prevention of Autoimmune Disease: The Type 1 Diabetes Paradigm
Harrison, L. C., & Wentworth, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00070-1 · Cited by 4
Lin, H. C., & Lin, D. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727798205.793561074
Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 1
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00910-8
“Typ-1-Diabetes zuerkranken,besteht [111, 117, 118].”
Probiotics in the Management of Diabetes
Mohi-ud-din, R., Mir, R. H., Farooq, S., Wani, T. U., Pottoo, F. H., Mohi-ud-din, A., & Bhat, Z. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_4 · Cited by 1
An Overview of Probiotics for Prevention and Treatment
Safdari, M., Razi, A., Safarirad, M., Pournaghi, S.-J., Shekari, S., Alesheikh, P., & Rameshrad, M. (2021) · Journal of North Khorasan University of Medical Sciences · doi:10.52547/nkums.13.1.64
Type I Diabetes and Human Microbiome
Madupu, R. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7475-4_754
Gut Microbiome and Human Health- A Brief Overview
E, A. N. M. B., Manjunatha, K., Nithin, B., Sri Charan, A., Usama Zaid, J., & Suman, P. (2022) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2022.47090 · Cited by 1
Maternal and Childhood Diet and Human Type 1 Diabetes Risk
Abela, A. G., & Fava, S. (2022) · Journal of Endocrinology and Metabolism · doi:10.14740/jem846
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_6 · Cited by 1
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-1997-7789 · Cited by 1
Ahmadi, S. H., & Daneshjoo, A. (2021) · Journal of Sports Physiology and Athletic Conditioning · doi:10.61186/jspac.19946.1.1.54
Zhao, J., Xing, W., Li, Y., Mao, Z., Wang, C., Zhang, S., Li, Z., Li, Y., Li, J., Yang, T., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3865977/v1
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2024) · Diabetes aktuell · doi:10.1055/a-2248-5316
Gut Microbiota Related Metabolites Changes - New Break through Point for Treating Diabetes
Li, J., Huang, X., Yanchun, P., & Pan, X. (2024) · Journal of Bacteriology and Mycology · doi:10.26420/jbacteriolmycol.2023.1200
Additional file 3 of Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Xi, L., Zhao, R., & Du, X. (2022) · Figshare · doi:10.6084/m9.figshare.19687015
Additional file 2 of Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Xi, L., Zhao, R., & Du, X. (2022) · Figshare · doi:10.6084/m9.figshare.19687012
Additional file 5 of Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Xi, L., Zhao, R., & Du, X. (2022) · Figshare · doi:10.6084/m9.figshare.19687021
Additional file 1 of Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Xi, L., Zhao, R., & Du, X. (2022) · Figshare · doi:10.6084/m9.figshare.19687009
Additional file 6 of Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Xi, L., Zhao, R., & Du, X. (2022) · Figshare · doi:10.6084/m9.figshare.19687024
Additional file 4 of Association of gut microbiota with idiopathic membranous nephropathy
Li, M., Wei, L., Sun, J., Zhu, Q., He, Y., Zhang, Y., Zhang, C., Xi, L., Zhao, R., & Du, X. (2022) · Figshare · doi:10.6084/m9.figshare.19687018
Why the need for microbiome? An updated perspective
Michael, O. S., Adetunji, J. B., Akinwale, E. O., Adetunji, C. O., & Soladoye, A. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00002-3 · Cited by 1
Disboyizisin Önlenmesi ve Sağlıklı Mikrobiyota Gelişimi için Probiyotikler
Çakır, A., Arslan, M., Sadioglu, O. D., Akdemir, T., Az, A., Güven, Ş., Ümit, T. B., Helvaci, M. S., Çalık, M., Coşkun, A., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3110
Lu, Q., & Xin, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00008-4
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2311-9952
LADA diabetes as an orphan disease and its connection with other autoimmune diseases
Garnytska, A. V., & Orlyk, O. S. (2024) · Infusion & Chemotherapy · doi:10.32902/2663-0338-2024-4-43-50
Jacobs, L., Mannie-Corbisier, L., Taghavi, M., & Nortier, J. (2025) · Bulletin de la Dialyse à Domicile · doi:10.25796/bdd.v8i1.86213
Dong, L., Hu, J., & Wang, F. (2025) · Research Square · doi:10.21203/rs.3.rs-6723420/v1
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01339-5
Jin, H., Feng, B., Gong, W., Chen, X., Wang, D., Li, Y., Huang, W., & Peng, W. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111126
Are Bifidobacterium Species Key Players in the Progression of Type 1 Diabetes? A Systematic Review
Vergoz, V., Jeong, D., & Hamilton‐Williams, E. E. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70120 · Cited by 1
Dietary Modulation of the Gut Microbiome: A Promising Approach for Management of Diabetes
Chukwudozie, K. I., Chukwudozie, I. C., & Onyeka, C. P. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i10.7423
Useinova, R. K., Beloglazov, V. A., Николаевна, Р. И., & Yatskov, I. A. (2025) · Obesity and metabolism · doi:10.14341/omet13137
Roth‐Schulze, A. J., Penno, M. A. S., Ngui, K., Oakey, H., Bandala‐Sanchez, E., Smith, A. D., Allnutt, T. R., Thomson, R. L., Vuillermin, P. J., Craig, M. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15128280
Wade, H., Pan, K., Duan, Q., Kaluzny, S., Pandey, E., Fatumoju, L., Saraswathi, V., Wu, R. R., Harris, E. N., & Su, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26595476
Consales, A., Toscano, L., Ceriotti, C., Tiraferri, V., Castaldi, S., & Giannì, M. L. (2024) · Figshare · doi:10.6084/m9.figshare.25591333
Gavin, P. G., Kim, K. W., Craig, M. E., Hill, M. M. C., & Hamilton‐Williams, E. E. (2023) · Figshare · doi:10.6084/m9.figshare.22611479
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D. F., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-8166
The Relationship between Diabetes Complications and the Intestinal Microbiota
Poczta, Z., Leśniak, C., Podeszwa, A., Różycka, M. A., Włoch, O., Siejek, A., Dobrowolska, A., & Zawada, A. E. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998408978251206123827
Zhou, M., Du, K., Wang, H., Zhang, Z., Zhao, R., Ma, C., Huang, Q., Zhang, W., & Chen, W. (2026) · Experimental Biology and Medicine · doi:10.3389/ebm.2026.10701
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
Role of gut antimicrobial peptides in autoimmune diabetes
Liang, W. (2022) · theses.fr (ABES) · doi:10.70675/c6de56d0z81a5z4ca8zb878z9a08dd3b00c4
Mazenc, A. (2022) · theses.fr (ABES) · doi:10.70675/993fac83z1efdz4dd2z8639z1373d18cf659
Role of MAIT cells in virally-induced type 1 diabetes by Coxsackievirus B4
Rouland, M. (2022) · theses.fr (ABES) · doi:10.70675/71d8ae9cz623cz4299zaa75zde7eff17dcf2
The Role of Microbiota in Type 1 Diabetes: Insights into Dysbiosis and Immune Interactions
Ignat, A., Anton, E., Săsăran, M. O., Tarnita, I., Ioniuc, I. K., Rusu, T. E., Moisă, Ș. M., Țarcă, E., Butnariu, L. I., Mitrofan, E. C., et al. (2026) · Nutrients · doi:10.3390/nu18121904
“In tandem with this shift, we observed a decrease in the diversity of the gut microbiome, a phenomenon previously noted in children with established T1D [33,34], as well as in autoantibody-positive individuals [35].”
Gao, Y.-L., Cui, M.-L., Sun, Y., Wang, S., Shang, J., Zheng, C.-H., & Liu, J.-X. (2026) · Lecture notes in computer science · doi:10.1007/978-981-92-3485-1_22
From Womb to World: Unravelling the Microbiota′s Impact on Health and Disease
Poterico, J. A., Babu, R. V., Jaramillo‐Valverde, L., Sánchez, C., Alayo, E. C., Valdivia‐Silva, J., & Guio, H. (2026) · International Journal of Microbiology · doi:10.1155/ijm/9228548
“Initially, studies showed decreased microbial diversity in both T1DM [77] and seroconverted children [78, 79], but this reduction was specific to seroconverts rather than undeveloped seroconverters [80].”
Ahmad, A., & Busair, E.-K. (2026) · Research Square · doi:10.21203/rs.3.rs-10630518/v1
Yang, S.-N., Chang, X.-Y., Peng, B.-K., Wei, Y., & Wang, Y.-P. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02462-0
“Members of Bacteroidota metabolize glucose and lactate to produce various short-chain fatty acids (SCFAs; e.g., succinate, acetate, and propionate), potentially disrupting intestinal homeostasis and contributing to autoimmune disease pathogenesis through altered immune modulation [26].”
Marza, T. N. H. (2026) · Insights in Clinical and Cellular Immunology · doi:10.29328/journal.icci.1001025
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus – Praxisempfehlung der DDG
Rubin, D. F., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2874-4204
The role of Akkermansia muciniphila in human disease: a friend or a foe?
HUANG, C., Zhang, Y., Xie, H., & Shi, G. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1974213
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.